Physician
Cardiology
Dr. Mark B. Effron, MD
Mark B. Effron is an expert in the field of Cardiology. He studied medicine at Johns Hopkins University School of Medicine. Johns Hopkins University School of Medicine is a top medical university. Johns Hopkins University School of Medicine is ranked 3/29 in Research/PrimaryCare. He received 1 awards: "Fellow (FACC)". Mark Effron is also published. He has 53 publications published. The lastest publication: "Randomized, placebo-controlled trial of platelet glycoprotein IIb/IIIa blockade with primary angioplasty for acute myocardial infarction. ReoPro and Primary PTCA Organ...'
Publications
- Comparative resource utilization and costs for patients with acute coronary syndrome managed with percutaneous coronary intervention and treated with clopidogrel or pr...
- Unplanned Inpatient and Observation Rehospitalizations After Acute Myocardial Infarction: Insights From the Treatment With Adenosine Diphosphate Receptor Inhibitors: L...
- Comparison of healthcare resource utilization and costs in patients hospitalized for acute coronary syndrome managed with percutaneous coronary intervention and receiv...
- "Real-World" comparison of prasugrel with ticagrelor in patients with acute coronary syndrome treated with percutaneous coronary intervention in the United States.
- Real-world observations with prasugrel compared to clopidogrel in acute coronary syndrome patients treated with percutaneous coronary intervention in the United States.
- Transferring from clopidogrel loading dose to prasugrel loading dose in acute coronary syndrome patients. High on-treatment platelet reactivity analysis of the TRIPLET...
- Enhanced active metabolite generation and platelet inhibitionwith prasugrel compared to clopidogrel regardless of genotype in thienopyridine metabolic pathways.
- Effect on Platelet Reactivity From a Prasugrel Loading Dose After a Clopidogrel Loading Dose Compared With a Prasugrel Loading Dose Alone: Transferring From Clopidogre...
- TransRadial Education and Therapeutics (TREAT): shifting the balance of safety and efficacy of antithrombotic agents in percutaneous coronary intervention: a report fr...
- Decrease in high on-treatment platelet reactivity (HPR) prevalence on switching from clopidogrel to prasugrel: Insights from the switching anti-platelet (SWAP) study.
- Treatment with Adenosine Diphosphate Receptor Inhibitors-Longitudinal Assessment of Treatment Patterns and Events after Acute Coronary Syndrome (TRANSLATE-ACS) study d...
- The onset of inhibition of platelet aggregation with prasugrel compared with clopidogrel loading doses using gatekeeping analysis of integrated clinical pharmacology d...
- Effects of the selective estrogen receptor modulator raloxifene on coronary outcomes in the Raloxifene Use for The Heart trial: results of subgroup analyses by age and...
- Impact of in-hospital acquired thrombocytopenia in patients undergoing primary angioplasty for acute myocardial infarction.
- Physical and chemical compatibility of drotrecogin alfa (activated) with 34 drugs during simulated Y-site administration.
- Two-dimensional echocardiographic features diagnostic of isolated pulmonic valve endocarditis.
- The effect of tadalafil on the time to exercise-induced myocardial ischaemia in subjects with coronary artery disease.
- False positive signal-averaged ECG produced by junctional rhythm with retrograde P waves.
- Mechanisms of blood flow during cardiopulmonary resuscitation.
- Feasibility and implications of an early discharge strategy after percutaneous intervention with abciximab in acute myocardial infarction (the CADILLAC Trial).
- Benefits and risks of abciximab use in primary angioplasty for acute myocardial infarction: the Controlled Abciximab and Device Investigation to Lower Late Angioplasty...
- A current review of olanzapine''s safety in the geriatric patient: from pre-clinical pharmacology to clinical data.
- Abciximab readministration: results of the ReoPro Readministration Registry.
- Abciximab and bleeding during coronary surgery: results from the EPILOG and EPISTENT trials. Improve Long-term Outcome with abciximab GP IIb/IIIa blockade. Evaluation ...
- Abciximab, ticlopidine, and concomitant abciximab-ticlopidine therapy: ex vivo platelet aggregation inhibition profiles in patients undergoing percutaneous coronary in...
- Platelet glycoprotein IIb/IIIa receptor antagonists and their use in elderly patients.
- Effects of abciximab, ticlopidine, and combined Abciximab/Ticlopidine therapy on platelet and leukocyte function in patients undergoing coronary angioplasty.
- Effect of glycoprotein IIb/IIIa inhibition without thrombolytic therapy on reperfusion in acute myocardial infarction: results of ReoMI pilot study.
- Effect of abciximab on the pattern of reperfusion in patients with acute myocardial infarction treated with primary angioplasty. RAPPORT investigators. ReoPro And Prim...
- Readministration of abciximab: interim report of the ReoPro readministration registry.
- Randomized, placebo-controlled trial of platelet glycoprotein IIb/IIIa blockade with primary angioplasty for acute myocardial infarction. ReoPro and Primary PTCA Organ...
- Effects of integrelin, a platelet glycoprotein IIb/IIIa receptor antagonist, in unstable angina. A randomized multicenter trial.
- Hemodynamic vascular forces contribute to impaired endothelium-dependent vasodilation in reperfused canine epicardial coronary arteries.
- Elastic properties of the human chest during cardiopulmonary resuscitation.
- Transient atrial dysfunction after conversion of chronic atrial fibrillation to sinus rhythm.
- Changes in myosin isoenzymes, ATPase activity, and contraction duration in rat cardiac muscle with aging can be modulated by thyroxine.
- Effects of resistive training on left ventricular function.
- Effects of diltiazem or propranolol during exercise training of hypertensive men.
- Exercise training combined with antihypertensive drug therapy. Effects on lipids, blood pressure, and left ventricular mass.
- Thrombolytic therapy for acute myocardial infarction in the 1990s.
- The use of a low-level stage during exercise testing in predicting severe coronary disease.
- Final results of the ReoPro readministration registry.
- Effect of tris(hydroxymethyl)aminomethane on ischemic myocardium.
- Treating patients with ''wake-up'' stroke: the experience of the AbESTT-II trial.
- Facilitated PCI in patients with ST-elevation myocardial infarction.
- Emergency administration of abciximab for treatment of patients with acute ischemic stroke: results of an international phase III trial: Abciximab in Emergency Treatme...
- A pharmacodynamic comparison of prasugrel vs. high-dose clopidogrel in patients with type 2 diabetes mellitus and coronary artery disease: results of the Optimizing an...
- Increased platelet inhibition after switching from maintenance clopidogrel to prasugrel in patients with acute coronary syndromes: results of the SWAP (SWitching Anti ...
- A prospective, observational study of Xigris Use in the United States (XEUS).
- Enoxaparin in primary and facilitated percutaneous coronary intervention A formal prospective nonrandomized substudy of the FINESSE trial (Facilitated INtervention wit...
- Benefit of facilitated percutaneous coronary intervention in high-risk ST-segment elevation myocardial infarction patients presenting to nonpercutaneous coronary inter...
- 1-year survival in a randomized trial of facilitated reperfusion: results from the FINESSE (Facilitated Intervention with Enhanced Reperfusion Speed to Stop Events) tr...
Schools
Johns Hopkins University School of Medicine
Doctors Specialties
- Cardiology
Accepted Insurances
Awards
- Fellow (FACC)
Education
-
Johns Hopkins University School of Medicine
Hospital
-
Ochsner Medical Center
Helpful Reviews
Similar Doctors
|
Dr. Milena Jani, MD
 This Doctor is OpenDoctor Recommended.
|
|
Dr. Jason C. Fleming, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Michael W. Ball, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Omar S. Obeidat, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jacqueline A. O'Donnell, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Peng-Sheng Chen, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ronald A. Mastouri, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. James H. Adlam, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Srinivas Vallapuri, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Deepak Bhakta, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Hussam S. Suradi, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Richard R. Schumacher, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Saurabh Malhotra, MD |
|
|
Dr. Jose E. Finet, MD
This Doctor is OpenDoctor Recommended.
|